World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
76
Citations
21211
World Ranking
18780
National Ranking
9358

Overview

Louis L. Pisters is affiliated with The University of Texas MD Anderson Cancer Center in the United States. Their research primarily focuses on various aspects of medicine, with an emphasis on pulmonary and respiratory medicine, surgery, molecular biology, cancer research, and neurology.

Their work covers several key topics within the medical field, including:

  • Prostate Cancer Treatment and Research
  • Prostate Cancer Diagnosis and Treatment
  • Testicular diseases and treatments
  • Sarcoma Diagnosis and Treatment
  • Cancer, Lipids, and Metabolism
  • Neuroblastoma Research and Treatments
  • Epigenetics and DNA Methylation

Louis L. Pisters has contributed to numerous publications, particularly in the following journals:

  • Cancers
  • Journal of Clinical Oncology
  • The Journal of Urology
  • Urologic Oncology Seminars and Original Investigations
  • Clinical Cancer Research

They have collaborated frequently with several co-authors, including:

  • John F. Ward
  • Brian F. Chapin
  • John W. Davis
  • Patricia Troncoso
  • Miao Zhang

Their recent notable papers include:

  • "Neoantigen responses, immune correlates, and favorable outcomes after ipilimumab treatment of patients with prostate cancer," 2020, Science Translational Medicine
  • "The MD Anderson Prostate Cancer Patient-derived Xenograft Series (MDA PCa PDX) Captures the Molecular Landscape of Prostate Cancer and Facilitates Marker-driven Therapy Development," 2020, Clinical Cancer Research
  • "Ductal Prostate Cancers Demonstrate Poor Outcomes with Conventional Therapies," 2020, European Urology
  • "Optimizing the diagnosis and management of ductal prostate cancer," 2021, Nature Reviews Urology
  • "Somatic-type Malignancies in Testicular Germ Cell Tumors," 2021, The American Journal of Surgical Pathology

Best Publications

  • Quality of life and satisfaction with outcome among prostate-cancer survivors.

    Martin G. Sanda;Rodney L. Dunn;Jeff Michalski;Howard M. Sandler

  • p53 Protein Accumulation and Gene Mutation in the Progression of Human Prostate Carcinoma

    Nora M. Navone;Patricia Troncoso;Louis L. Pisters;Tamra L. Goodrow

  • C-met Proto-Oncogene Expression in Benign and Malignant Human Prostate Tissues

    Louis L. Pisters;Adel K. El-Naggar;Weiping Luo;Anais Malpica

  • Presalvage prostate-specific antigen (PSA) and PSA doubling time as predictors of biochemical failure of salvage cryotherapy in patients with locally recurrent prostate cancer after radiotherapy.

    Philippe E. Spiess;Andrew K. Lee;Dan Leibovici;Xuemei Wang

  • Surgical management of renal cell carcinoma with inferior vena cava tumor thrombus

    Jonathan C Nesbitt;Ernesto R Soltero;Colin P.N Dinney;Garrett L Walsh

  • Multimodality Management of Urachal Carcinoma: The M. D. Anderson Cancer Center Experience

    Arlene O Siefker-Radtke;Jason R. Gee;Yu-Lin Shen;Sijin Wen

  • Prediction of Erectile Function Following Treatment for Prostate Cancer

    Mehrdad Alemozaffar;Meredith M. Regan;Matthew R. Cooperberg;John T. Wei

  • Micropapillary bladder cancer: a review of the University of Texas M. D. Anderson Cancer Center experience with 100 consecutive patients.

    Ashish M. Kamat;Colin P. N. Dinney;Jason R. Gee;H. Barton Grossman

  • Best practice statement on cryosurgery for the treatment of localized prostate cancer.

    Richard J. Babaian;Bryan Donnelly;Duke Bahn;John G. Baust

  • The Efficacy and Complications of Salvage Cryotherapy of the Prostate

    Louis L. Pisters;Andrew C. von Eschenbach;Shellie M. Scott;David A. Swanson

  • Evidence supporting preoperative chemotherapy for small cell carcinoma of the bladder: a retrospective review of the M. D. Anderson cancer experience.

    Arlene O. Siefker-Radtke;Colin P. Dinney;Neil A. Abrahams;Cesar Moran

  • PCAT-1, a long noncoding RNA, regulates BRCA2 and controls homologous recombination in cancer

    John R. Prensner;Wei Chen;Matthew K. Iyer;Qi Cao

  • PROGNOSTIC FACTORS AND SURVIVAL OF PATIENTS WITH SARCOMATOID RENAL CELL CARCINOMA

    Badar M Mian;Nishin A. Bhadkamkar;Joel W. Slaton;Peter W. T. Pisters

  • The case for early cystectomy in the treatment of nonmuscle invasive micropapillary bladder carcinoma.

    Ashish M. Kamat;Jason R. Gee;Colin P.N. Dinney;H. Barton Grossman

  • Depressive Symptoms and Cortisol Rhythmicity Predict Survival in Patients with Renal Cell Carcinoma: Role of Inflammatory Signaling

    Lorenzo Cohen;Steven W. Cole;Anil K. Sood;Sarah Prinsloo

  • Sentinel Lymph Node Dissection for Penile Carcinoma: The M. D. Anderson Cancer Center Experience

    Curtis A. Pettaway;Louis L. Pisters;Colin P.N. Dinney;Fe Jularbal

  • Salvage Prostate Cryoablation: Initial Results From the Cryo On-Line Data Registry

    Louis L. Pisters;John C. Rewcastle;Bryan J. Donnelly;Franco M. Lugnani

  • ADULT PROSTATE SARCOMA: THE M. D. ANDERSON CANCER CENTER EXPERIENCE

    Wade J. Sexton;Raymond E. Lance;Adriana O. Reyes;Peter W.T. Pisters

  • Lymph Node Density Is Superior to TNM Nodal Status in Predicting Disease-Specific Survival After Radical Cystectomy for Bladder Cancer: Analysis of Pooled Data From MDACC and MSKCC

    Wassim Kassouf;Piyush K. Agarwal;Harry W. Herr;Mark F. Munsell

  • An Assessment of Quality of Life Following Radical Prostatectomy, High Dose External Beam Radiation Therapy and Brachytherapy Iodine Implantation as Monotherapies for Localized Prostate Cancer

    Steven Jay Frank;Louis L Pisters;John W Davis;Andrew K. Lee

Frequent Co-Authors

Curtis A. Pettaway
Curtis A. Pettaway The University of Texas MD Anderson Cancer Center
Ashish M. Kamat
Ashish M. Kamat The University of Texas MD Anderson Cancer Center
Colin P. Dinney
Colin P. Dinney The University of Texas MD Anderson Cancer Center
Deborah A. Kuban
Deborah A. Kuban The University of Texas MD Anderson Cancer Center
Patricia Troncoso
Patricia Troncoso The University of Texas MD Anderson Cancer Center
Christopher G. Wood
Christopher G. Wood The University of Texas MD Anderson Cancer Center
Surena F. Matin
Surena F. Matin The University of Texas MD Anderson Cancer Center
Christopher J. Logothetis
Christopher J. Logothetis The University of Texas MD Anderson Cancer Center
Xuemei Wang
Xuemei Wang The University of Texas MD Anderson Cancer Center
H. Barton Grossman
H. Barton Grossman The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative pathways in healthcare is an excellent option for students interested in Medicine or seeking flexible learning options. Today, many healthcare careers can be started or advanced through online degrees, featuring various specializations, structures, and pricing.

For those considering healthcare management roles, knowing how to evaluate healthcare administration degree programs is vital. Accreditation, program format, and curriculum relevance are key factors to assess.

Nurses aiming to advance their qualifications can benefit from online rn to bsn programs no clinicals, which provide a flexible, accessible route to a BSN without in-person requirements. For those seeking leadership or advanced clinical roles, pursuing accelerated dnp programs online offers a fast-tracked way to earn a terminal nursing degree, while cheapest online dnp programs can reduce the financial burden.

These options cater to various career goals and life situations, making it easier than ever to advance in the healthcare field without putting your life on hold.

Best Scientists Citing Louis L. Pisters

Trending Scientists